BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22916481)

  • 1. [Study of the management of clinical trial in the registration of medical devices in China].
    Du R; Ouyang Z; Guo K; Chi H
    Zhongguo Yi Liao Qi Xie Za Zhi; 2012 May; 36(3):206-9. PubMed ID: 22916481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical device registration system comparison between China and U.S.A].
    Yue W
    Zhongguo Yi Liao Qi Xie Za Zhi; 2009 Jan; 33(1):51-8. PubMed ID: 19459353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial requests of indigenous diagnostic imaging ultrasound devices in first-time registration application].
    Guo Z; Cao G; Tao K
    Zhongguo Yi Liao Qi Xie Za Zhi; 2012 Nov; 36(6):438-40. PubMed ID: 23461122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the reform and improvement of the medical device registration system in China].
    Wang L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2012 Nov; 36(6):426-32. PubMed ID: 23461120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A].
    Sun Q; Yan L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Jan; 30(1):43-52. PubMed ID: 16646425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization devices: the Food and Drug Administration's regulatory considerations.
    Moynahan M; Faris OP; Lewis BM
    J Am Coll Cardiol; 2005 Dec; 46(12):2325-8. PubMed ID: 16360066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient safety and efficacy as measured by clinical trials and regulatory policy.
    Harvey BE; Alpert S
    Stud Health Technol Inform; 1997; 39():75-9. PubMed ID: 10168957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis on current laws and regulations of medical device clinical trial in China].
    Wang Y; Li T; Liang N
    Zhongguo Yi Liao Qi Xie Za Zhi; 2014 Jan; 38(1):61-4. PubMed ID: 24839854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk management of European device clinical studies.
    Donawa M
    Med Device Technol; 2007; 18(2):39-42. PubMed ID: 17494500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of device labeling regulation in U.S.A. and China].
    Li F; Wei J; Ma Y; Li Z
    Zhongguo Yi Liao Qi Xie Za Zhi; 2010 Sep; 34(5):374-7. PubMed ID: 21179718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Status Analysis and Improvement Suggestions on the Renew Registration of Passive Medical Devices].
    Hou D; Chu Y; Zhong Z
    Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Sep; 42(5):375-377. PubMed ID: 30358356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standards, guidelines and principles for clinical trials: medical products].
    Ziegler WJ; Perren SM
    Swiss Surg; 1995; (1):81-3. PubMed ID: 8581810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices on trial, Part I.
    Wright D
    Med Device Technol; 2002 Dec; 13(10):35-8. PubMed ID: 12575529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discussions on the regulatory requirements for medical device risk management in China].
    Wang LM
    Zhongguo Yi Liao Qi Xie Za Zhi; 2009 Jan; 33(1):46-50. PubMed ID: 19459352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed amendments to the medical devices Directives.
    Donawa M
    Med Device Technol; 2006; 17(1):22-5. PubMed ID: 16483107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian statistics in medical devices: innovation sparked by the FDA.
    Campbell G
    J Biopharm Stat; 2011 Sep; 21(5):871-87. PubMed ID: 21830920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to assess new medical devices].
    Bernard A; Vicaut E
    J Chir (Paris); 2009 Apr; 146(2):129-35. PubMed ID: 19524920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.